$IOT CUSTOM 270115 CALL 48.0/PUT 30.0/CALL 40.0/PUT 35.0$
What actually draws investors to Samsara (IOT)
The pitch rests on one unusual combination: a company growing near 30% at scale while already generating cash. That pairing is rare enough that investors tolerate a very rich multiple to own it.
The five factors that carry the story
1. Growth at scale - Q2 FY27 revenue $415.5M, +30.6% YoY; net new ARR $134.1M (+28%); FY27 guide $2.043–2.047B. Few companies above $1B revenue sustain ~30% growth. It's the core of the thesis.
2. Cash generation, not just accounting profit - H1 operating cash flow $154.9M, +50.8% YoY; Q2 FCF margin ~13%. Growth is funded internally. This is the difference between a "story stock" and a business.
3. Enterprise land-and-expand - $1M+ ARR cohort growing >50% for 3 straight quarters, contributing >$500M ARR Proves the upsell motion works — customers don't just sign, they scale. This is the highest-quality revenue signal in the model.
4. Large, underpenetrated market - Connected operations software spanning fleet telematics, video safety, equipment and industrial IoT. Multiple expansion vectors from one platform; no single end-market dependency.
5. AI optionality - Agent Studio with no-code AI chat/voice agents; AI-agent usage up 7x since June. Free upside on the narrative, though not yet quantified in revenue.
The attraction and the risk are the same fact viewed from two sides:
* Valuation: 13.4x TTM sales, 53.8x forward P/E, 274.7x TTM GAAP P/E.
* GAAP profitability is thin: H1 operating income $13.9M on $1.14B revenue — roughly 1.2% margin.
* SBC is 19.9% of revenue ($101.1M in Q2), which is most of the gap between non-GAAP and GAAP earnings.
So the bull case is explicitly a bet that growth durability outruns multiple compression — that net new ARR keeps compounding fast enough for the sales multiple to be earned down rather than repriced.
Supporting sentiment
27 analysts cover it with no sell ratings (22.2% strong buy, 55.6% buy, 22.2% hold), mean target $51.81. Short interest at 8.32 days-to-cover — the highest since May 2026 — adds a squeeze element if the December print lands well.
What would sour the attraction
Net new ARR below ~$120M, the $1M+ cohort decelerating, or SBC staying near 20% of revenue while GAAP margin stalls. Any of those turns "profitable growth" back into "expensive growth," and at 13.4x sales there is little multiple cushion to absorb it.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- tinkie·11-12 22:44TOPThat $134.1M net new ARR is the number doing the work here, especially with the $1M+ cohort still compounding above 50%. If that holds, the rich multiple gets digestedLikeReport
- mizzmo·11-12 22:4419.9% SBC against a 1.2% GAAP margin is still doing a lot of the heavy liftingLikeReport